Abdominal wall repair (AWR) for hernia is a common procedure, with an estimated 1 million or more procedures performed each year in the United States.^[@i0020-8868-99-3-235-b01]^ Incisional hernias are a common complication of AWR, with reported incidences ranging from 9% to 20% in prospective studies of patients undergoing abdominal surgery.^[@i0020-8868-99-3-235-b02]--[@i0020-8868-99-3-235-b07]^ Significant advances have been made in surgical repair of abdominal hernias in recent decades, including the use of components separation techniques^[@i0020-8868-99-3-235-b08],[@i0020-8868-99-3-235-b09]^ and prosthetic mesh and biologic tissue matrix materials to facilitate closure of abdominal wall defects.^[@i0020-8868-99-3-235-b09]^ Nevertheless, data from several retrospective studies have shown hernia recurrence remains a significant problem following AWR using components separation techniques, with recurrence rates ranging from 14% to 22%.^[@i0020-8868-99-3-235-b10]--[@i0020-8868-99-3-235-b13]^ Synthetic mesh or biologic tissue matrix materials can be used to provide additional reinforcement in AWR with or without components separation. Reported recurrence rates following repair with prosthetic materials are highly variable^[@i0020-8868-99-3-235-b14]--[@i0020-8868-99-3-235-b17]^ and can be impacted by the complexity of the individual patient case, number of previous hernia repairs, and surgeon\'s technique.^[@i0020-8868-99-3-235-b09],[@i0020-8868-99-3-235-b18]^ While there is lack of consensus regarding which mesh or matrix type to use for reinforcement in AWR, according to the Ventral Hernia Working Group (VHWG), synthetic mesh should be avoided in patients classified as having grade 2 risk (*e.g*., those who are smokers, obese, diabetic, immunosuppressed or have chronic obstructive pulmonary disease) owing to the increased risk of postoperative infection associated with comorbidities.^[@i0020-8868-99-3-235-b09]^

Biologic tissue matrices may offer advantages over synthetic mesh for AWR in high-risk patients (*e.g*., better revascularization, less infection).^[@i0020-8868-99-3-235-b09],[@i0020-8868-99-3-235-b19],[@i0020-8868-99-3-235-b20]^ Non--cross-linked intact porcine-derived acellular dermal matrix (PADM; Strattice Reconstructive Tissue Matrix, LifeCell Corp, Branchburg, New Jersey) is designed to perform as a surgical matrix for soft-tissue repair while serving as a scaffold for the rapid ingrowth of host cells, collagen, and blood vessels.^[@i0020-8868-99-3-235-b21],[@i0020-8868-99-3-235-b22]^ In our practice, we have observed high complication rates following complex AWR with synthetic mesh in patients who have multiple risk factors with or without potentially contaminated or infected surgical fields. The objective of this study was to assess and describe postoperative outcomes in a consecutive cohort of patients who underwent ventral hernia repair using components separation techniques and reinforcement with PADM.

Patients and Methodology {#s2}
========================

This retrospective, Institutional Review Board--approved study included consecutive patients who underwent ventral hernia repair with components separation with PADM reinforcement performed by the author at the University of Pittsburgh Medical Center (Pittsburgh, Pennsylvania) and Butler Memorial Hospital (Butler, Pennsylvania). Surgeries were performed between August 2008 and January 2012, with follow-up data available through February 2013. Information on patient demographics, comorbidities, relevant medical and surgical history, presence of previously placed mesh, and length of surgical incision were recorded.

Prior to surgery, smokers were advised regarding smoking cessation, and all patients received prophylactic antibiotics. Ventral hernia repair, including components separation with bilateral dissection of the external oblique to the inferior portion of the pectoralis major muscle ([Fig. 1](#i0020-8868-99-3-235-f01){ref-type="fig"}), removal (if possible) of any previously placed mesh, and placement of PADM was performed in all patients according to the author\'s usual technique. For midline closure, interrupted No. 1 Prolene monofilament nonabsorbable (Ethicon, Inc, Somerville, New Jersey), or No. 1 Surgipro monofilament nonabsorbable (Covidien, Mansfield, Massachusetts) sutures were used. PADM was overlaid in a medial position across the anterior side of the rectus abdominis and sutured into place with interrupted Maxon No. 1 monofilament absorbable sutures (Covidien) to reinforce midline closure ([Fig. 2](#i0020-8868-99-3-235-f02){ref-type="fig"}). Two size-19 French Blake drains (Ethicon) were placed in all patients and remained in place until drainage was \<30 mL for 2 consecutive days. All patients received intravenous cefazolin for 24 hours after surgery. Postoperative pain was managed with intravenous or orally administered analgesics, as needed.

![Anterior abdominal wall showing anatomic location of midline incision and components separation.](i0020-8868-99-3-235-f01){#i0020-8868-99-3-235-f01}

![Midline closure showing overlay of non--cross-linked porcine-derived acellular dermal matrix in place.](i0020-8868-99-3-235-f02){#i0020-8868-99-3-235-f02}

Postoperative Assessments {#s3}
=========================

Postoperative outcomes assessed included seroma, evidenced by localized accumulation of fluid in the perioperative area, confirmed via computed tomography (CT) evaluation; wound infection, based on presence of erythema, exudate, tenderness, pain, and/or fever, as well as positive blood or tissue culture results; deep-vein thrombosis, identified by clinical signs and symptoms including swelling, pain, and color changes in the affected area, and confirmed based on ultrasound imaging; and bleeding. Hernia recurrence was diagnosed based on clinical or CT evaluation; any patient with a palpable mass, pain, swelling, or bulge extending beyond the reestablished abdominal wall boundary was identified as a possible hernia recurrence and confirmed based on ultrasound examination. Follow-up visits occurred at 1, 3, 6, 9, and 12 months after surgery and yearly thereafter. Complications, including hernia recurrence, were determined through clinical examination.

Results {#s4}
=======

A total of 47 patients were included in the study. Patient demographics and clinical characteristics are summarized in [Table 1](#i0020-8868-99-3-235-t01){ref-type="table"}. The majority of patients were female (68%) and obese \[body mass index (BMI) \>30 kg/m^2^, 60%\], and most (64%) were classified as having VHWG grade 2 or grade 3 risk for postoperative complications at the surgical site.^[@i0020-8868-99-3-235-b09]^ Other comorbidities that were present in ≥5% of the study population included diabetes (n = 14, 30%), history of cancer (n = 6, 13%), chronic obstructive pulmonary disease (n = 4, 9%), and history of deep-vein thrombosis (n = 3, 6%).

###### 

Patient demographics and characteristics

![](i0020-8868-99-3-235-t01)

Twenty-three patients (49%) had undergone previous ventral herniorrhaphy. The number of previous herniorrhaphies in the total study sample ranged from 0 to 11 (median, 0); the majority of patients (79%) had ≤1 previous repair. The mean (SD) length of surgical incision was 26 (9) cm. Primary fascial closure was achieved, and PADM was successfully placed in all 47 patients. PADM sheet sizes ranged from 6 × 16 cm to 6 × 20 cm. Herniorrhaphy was performed in the setting of infected previously placed mesh in 5 patients (11%), and the infected mesh was removed during surgery in all of these patients. Concurrent surgical procedures performed included panniculectomy in 3 patients. The mean (SD) length of hospital stay was 8 (6) days (median, 6 days; range, 2--29 days).

Patients were followed for a mean (SD) duration 31 (12) months (median, 34 months; range, 13--54 months). Of the 47 patients in the study, 31 were followed for ≥2 years. Overall, 12 patients experienced a total of 14 postoperative complications (3 hernia recurrences and 11 other complications; [Table 2](#i0020-8868-99-3-235-t02){ref-type="table"}). Of the 3 patients (6%) who experienced hernia recurrence during the follow-up period, 2 had recurrences at 18 months postsurgery and 1 had recurrence at 7 months postsurgery. The patient with recurrence at 7 months was an 85-year-old, nonobese (BMI, 25 kg/m^2^) man who had 2 previous herniorrhaphies. He had no other relevant comorbidities and was classified as having VHWG grade 1 risk at the time of the most recent surgery. One patient who had a hernia recurrence at 18 months postsurgery was a 50-year-old, morbidly obese (BMI, 46 kg/m^2^) man with no previous history of hernia repair surgery. He had VHWG grade 2 risk for postsurgical complications and no other relevant comorbidities at the time of surgery. The other patient who experienced hernia recurrence at 18 months after surgery was a 75-year-old obese (BMI, 36 kg/m^2^) woman who had a history of 11 previous ventral hernia repair procedures. She had a previously placed infected mesh removed during her most recent surgery (VHWG grade 4 risk).

###### 

Summary of postoperative complications
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Nine of the 47 (19%) patients experienced 11 other postoperative complications, including deep-vein thrombosis (n = 4), seroma (n = 3), wound infection (n = 2), and bleeding (n = 2).

Discussion {#s5}
==========

In this cohort of patients, ventral hernia repair with use of components separation and non--cross-linked PADM resulted in low rates of postsurgical complications. Overall, 75% of patients did not experience any postsurgical complications, and only 3 experienced a recurrent hernia during a mean follow-up of approximately 2.5 years. These observations are particularly encouraging given that about half of the patients included in the study had undergone one or more previous ventral hernia repairs. Prior abdominal surgery is a known risk factor for hernia recurrence,^[@i0020-8868-99-3-235-b23],[@i0020-8868-99-3-235-b24]^ and this risk increases with each subsequent repair.^[@i0020-8868-99-3-235-b25]^

The risk of postsurgical complications after AWR with prosthetic mesh placement can be impacted by numerous factors, including patient comorbidities, the complexity of the patient\'s condition at the time of surgery, the surgeon\'s techniques for prosthetic mesh placement, the specific physical and/or chemical properties of the individual matrix or mesh,^[@i0020-8868-99-3-235-b09]^ and the time elapsing since hernia repair. Reported rates of recurrence across studies of synthetic mesh in AWR range from 4% to 32%,^[@i0020-8868-99-3-235-b12],[@i0020-8868-99-3-235-b14]--[@i0020-8868-99-3-235-b16],[@i0020-8868-99-3-235-b18],[@i0020-8868-99-3-235-b20],[@i0020-8868-99-3-235-b26]--[@i0020-8868-99-3-235-b29]^ with a mean of approximately 19% across studies. Reported recurrence rates following placement of biologic tissue matrix range between 0% and 44%,^[@i0020-8868-99-3-235-b12],[@i0020-8868-99-3-235-b20],[@i0020-8868-99-3-235-b30]--[@i0020-8868-99-3-235-b43]^ with a mean of approximately 12% across studies, compared with the recurrence rate of 6% observed in the current study.

There have been several previous reports of results from prospective^[@i0020-8868-99-3-235-b35]^ and retrospective^[@i0020-8868-99-3-235-b30],[@i0020-8868-99-3-235-b36],[@i0020-8868-99-3-235-b42]^ studies of PADM use in complex AWR. It is not surprising that incidences of postsurgical complications observed in the current study were lower than complication rates in previous studies involving populations that largely comprised patients with potentially contaminated (VHWG grade 3) or infected (VHWG grade 4) surgical sites.^[@i0020-8868-99-3-235-b30],[@i0020-8868-99-3-235-b35],[@i0020-8868-99-3-235-b36]^ One previous study included a population largely comprising patients with VHWG grade 2 risk for postsurgical complications, as in the current study. Patel and colleagues^[@i0020-8868-99-3-235-b42]^ retrospectively assessed postsurgical outcomes following AWR with components separation and PADM in a cohort of 41 patients; of whom, 33 (81%) were classified as having VHWG grade 2 risk for postsurgical complications. The authors observed incidences of seroma, wound infection, and hernia recurrence of 7%, 2%, and 0%, respectively, at a mean follow-up of 16 months. In the current study, the incidences of seroma, wound infection, and hernia recurrence were 6%, 4%, and 6%, respectively, in a population that had 62% of patients classified as VHWG grade 2 risk followed for a mean of 31 months. The high incidence of postoperative deep-vein thrombosis (9%) in the current study may be explained by patient histories. Of the 4 patients who experienced deep-vein thrombosis, 1 was a cancer patient who was also a smoker with chronic obstructive pulmonary disease, and he had a previously placed infected mesh removed during the current surgery (*i.e*., classified as VHWG grade 4 risk). The other 3 patients with deep-vein thrombosis were classified as having grade 2 risk, though all 3 were smokers and 2 were obese.

Interpretation of the results of this study is limited by its retrospective design; the fact that the study included a heterogeneous group of patients undergoing surgery at one health system by a single surgeon; the lack of a control group or comparator; and its limited duration of follow-up. It will be important to continue follow-up on these patients to evaluate long-term outcomes.

Conclusion {#s6}
==========

The use of non--cross-linked PADM for reinforcement following components separation in complex ventral hernia repair resulted in low rates of postoperative complications and hernia recurrence in this patient cohort. Continued follow-up of these patients will be key for evaluating the long-term success of this approach for ventral hernia repair.
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